Literature DB >> 7104190

Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.

A A Epenetos, C C Nimmon, J Arklie, A T Elliott, L A Hawkins, R W Knowles, K E Britton, W F Bodmer.   

Abstract

Monoclonal antibodies to epithelial-cell antigenic determinants, labelled with 123I and 125I, were administered parenterally to immunodeficient mice bearing human tumours derived from a human cancer cell line. Anterior, posterior and lateral radioscans of the body were taken with a gamma scintillation camera at various times from immediately to 65 days after injection. Visual displays of the images were processed by standard computer techniques. The model used a human colon-cancer cell line, HT29, and the monoclonal antibody, AUA1, which is specific to an epithelial proliferating antigen. Tumour detection was achieved in all the mice. The smallest tumour detectable appeared to be about 1 mm in diameter. The degree of antibody uptake in a tumour depended on its size and the blood supply of its surrounding tissues We believe that the technology and skills are now available for accurate radioimmunodetection of cancer in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104190      PMCID: PMC2011073          DOI: 10.1038/bjc.1982.157

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  The localization of antilymphosarcoma antibodies in the Murphy lymphosarcoma of the rat.

Authors:  L KORNGOLD; D PRESSMAN
Journal:  Cancer Res       Date:  1954-02       Impact factor: 12.701

2.  Structure and function of immunoglobulin domains. V. Binding, University of immunoglobulin G and fragments to placental membrane preparations.

Authors:  T McNabb; T Y Koh; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

7.  Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.

Authors:  D M Goldenberg; E E Kim; F H DeLand; S Bennett; F J Primus
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

8.  Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers.

Authors:  J Arklie; J Taylor-Papadimitrious; W Bodmer; M Egan; R Millis
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

9.  Imaging approach in radioimmunodetection.

Authors:  F H DeLand; E E Kim; G Simmons; D M Goldenberg
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

10.  Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.

Authors:  V Moshakis; R A McIlhinney; D Raghavan; A M Neville
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

View more
  14 in total

1.  Optimal tumor targeting by antibodies: development of a mathematical model.

Authors:  M J Chappell; G D Thomas; K R Godfrey; A R Bradwell
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

2.  Monoclonal antibody uptake in B-cell lymphomas: experimental studies in nude mouse xenografts.

Authors:  J Schmid; P Möller; G Moldenhauer; B Dörken; H Bihl; S Matzku
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Expression of MAM-3 and MAM-6 antigens in endometrial and endocervical adenocarcinomas.

Authors:  A Tsubura; S Morii; J Hilkens; J Hilgers
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

4.  Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.

Authors:  Robert M Sharkey; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Journal:  Cancer Biother Radiopharm       Date:  2010-02       Impact factor: 3.099

5.  Localization of experimental glioma grafts by means of iodinated monoclonal antibodies and radionuclide imaging.

Authors:  D Stavrou; W Mellert; T Bilzer; R Senekowitsch; E Keiditsch; P Mehraein
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

Review 6.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  The detection of virally induced tumors by 131I- and 125I-labeled syngeneic monoclonal antibodies.

Authors:  D Berends; J L van Gaalen; E H Rhijnsburger; N J de Both; W Breeman; W H Bakker; P Kooy
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Immunodetection of thyroid tumors: role of immuno aggregates.

Authors:  A J Van Herle; B Estour; G Juillard; A Giuliano; R A Hawkins; K Van Herle
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

9.  The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissues.

Authors:  H R Zenklusen; C Stähli; F Gudat; J von Overbeck; J Rolink; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 10.  Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.

Authors:  R W Baldwin; M V Pimm
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.